Related Experiment Video
Updated: May 31, 2026
08:53
In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
Monoclonal antibodies in ophthalmology
N R Biswas1, G K Das, A K Dubey
1BP Koirala (BPKIHS) Institute of Health Sciences, Dharan, Nepal. nrbiswas@hotmail.com
Nepal Medical College Journal : NMCJ
|July 13, 2011
Summary
Monoclonal antibodies effectively treat inflammatory eye diseases by targeting specific molecules. These advanced therapies show promise for sight-threatening conditions resistant to traditional treatments.
Area of Science:
- Ophthalmology
- Immunology
- Biotechnology
Background:
- Cytokines significantly contribute to ocular inflammatory diseases like diabetic retinopathy and macular degeneration.
- Monoclonal antibodies offer targeted therapy for various eye conditions.
Purpose of the Study:
- To review the role and efficacy of monoclonal antibodies in managing ocular inflammatory and neovascular disorders.
- To highlight the potential of these biologics in treating sight-threatening eye diseases.
Main Methods:
- Review of existing literature on monoclonal antibody applications in ophthalmology.
- Analysis of therapeutic targets including VEGF, TNF-alpha, CD20, CD52, CD11a, and IL-2.
- Evaluation of clinical outcomes for conditions like proliferative diabetic retinopathy, neovascular age-related macular degeneration, and glaucoma.
Main Results:
- Monoclonal antibodies targeting VEGF and TNF-alpha have shown positive results in controlling ocular neovascularization and inflammation.
- Therapies targeting CD markers and IL-2 are being explored for various ocular pathologies.
- Significant positive responses observed in sight-threatening eye disorders refractory to conventional treatments.
Conclusions:
- Monoclonal antibodies represent a promising therapeutic strategy for diverse ocular conditions.
- Continued research and understanding of molecular pathways will expand their application.
- Despite cost and long-term safety considerations, judicious use offers immense potential in ophthalmic patient management.
Related Concept Videos
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...